43 related articles for article (PubMed ID: 18588258)
1. Review: epoetin and darbepoetin reduce need for blood transfusions but increase risk for thrombosis in patients with cancer.
Steensma DP
ACP J Club; 2008 Jun; 148(4):7. PubMed ID: 18588258
[No Abstract] [Full Text] [Related]
2. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
3. Epoetin delta: efficacy in the treatment of anaemia in cancer patients receiving chemotherapy.
Krzakowski M;
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):705-13. PubMed ID: 18691854
[TBL] [Abstract][Full Text] [Related]
4. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
Chan A; Lim LL; Tao M
Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
[TBL] [Abstract][Full Text] [Related]
5. Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.
Christodoulou C; Dafni U; Aravantinos G; Koutras A; Samantas E; Karina M; Janinis J; Papakostas P; Skarlos D; Kalofonos HP; Fountzilas G
Anticancer Res; 2009 Feb; 29(2):693-702. PubMed ID: 19331224
[TBL] [Abstract][Full Text] [Related]
6. Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.
Glaspy JA; Charu V; Luo D; Moyo V; Kamin M; Wilhelm FE
Cancer; 2009 Mar; 115(5):1121-31. PubMed ID: 19170225
[TBL] [Abstract][Full Text] [Related]
7. VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia.
Dronca RS; Steensma DP
Nat Clin Pract Oncol; 2008 Sep; 5(9):504-5. PubMed ID: 18648351
[TBL] [Abstract][Full Text] [Related]
8. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
Heras P; Kritikos K; Hatzopoulos A; Mitsibounas D
Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia.
Tzekova V; Mihaylov G; Elezovic I; Koytchev R;
Curr Med Res Opin; 2009 Jul; 25(7):1689-97. PubMed ID: 19505200
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.
Han HS; Han JY; Yu SY; Pyo HR; Kim HY; Cho KH; Lee DH; Kim HT; Lee JS
Cancer; 2008 Oct; 113(7):1623-31. PubMed ID: 18671241
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cancer-related anemia.
Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
[TBL] [Abstract][Full Text] [Related]
12. [Supportive care administering medical treatment (including growth factors) in thoracic oncology].
Urban T
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S151-9. PubMed ID: 18971840
[TBL] [Abstract][Full Text] [Related]
13. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
14. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
15. Microparticles and thrombotic disease.
Davizon P; López JA
Curr Opin Hematol; 2009 Sep; 16(5):334-41. PubMed ID: 19606028
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
Bell D; Grimes D; Gurney H; Dalley D; Blackwell T; Fox R; Jeffery M
Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated thrombosis.
Sood SL
Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
[TBL] [Abstract][Full Text] [Related]
18. Anemia management in oncology and hematology.
Spivak JL; Gascón P; Ludwig H
Oncologist; 2009; 14 Suppl 1():43-56. PubMed ID: 19762516
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of venous thrombosis.
López JA; Chen J
Thromb Res; 2009; 123 Suppl 4():S30-4. PubMed ID: 19303501
[TBL] [Abstract][Full Text] [Related]
20. Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin.
Muravyov AV; Cheporov SV; Kislov NV; Volkova EL
Clin Hemorheol Microcirc; 2009; 41(1):39-47. PubMed ID: 19136741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
